| Azithromycin: mechanisms of action and their relevance for clinical applications MJ Parnham, VE Haber, EJ Giamarellos-Bourboulis, G Perletti, ... Pharmacology & therapeutics 143 (2), 225-245, 2014 | 701 | 2014 |
| Anti-inflammatory effects of macrolide antibiotics O Čulić, V Eraković, MJ Parnham European journal of pharmacology 429 (1-3), 209-229, 2001 | 490 | 2001 |
| Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects O Čulić, V Eraković, I Čepelak, K Barišić, K Brajša, Ž Ferenčić, R Galović, ... European journal of pharmacology 450 (3), 277-289, 2002 | 334 | 2002 |
| Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin M Bosnar, Z Kelneric, V Munic, V Erakovic, MJ Parnham Antimicrobial agents and chemotherapy 49 (6), 2372-2377, 2005 | 213 | 2005 |
| Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment. MJ Parnham, O Culić, V Eraković, V Munić, S Popović-Grle, K Barisić, ... European journal of pharmacology 517 (1-2), 132, 2005 | 135 | 2005 |
| Azithromycin and clarithromycin inhibit lipopolysaccharide-induced murine pulmonary neutrophilia mainly through effects on macrophage-derived granulocyte-macrophage colony … M Bosnar, B Bošnjak, S Čužić, B Hrvačić, N Marjanović, I Glojnarić, ... Journal of pharmacology and experimental therapeutics 331 (1), 104-113, 2009 | 124 | 2009 |
| Azithromycin distinctively modulates classical activation of human monocytes in vitro M Vrančić, M Banjanac, K Nujić, M Bosnar, T Murati, V Munić, ... British journal of pharmacology 165 (5), 1348-1360, 2012 | 118 | 2012 |
| Anti-inflammatory activity of azithromycin attenuates the effects of lipopolysaccharide administration in mice VI Tkalčević, B Bošnjak, B Hrvačić, M Bosnar, N Marjanović, Ž Ferenčić, ... European journal of pharmacology 539 (1-2), 131-138, 2006 | 105 | 2006 |
| Lithium plus pilocarpine induced status epilepticus—biochemical changes V Eraković, G Župan, J Varljen, J Laginja, A Simonić Neuroscience research 36 (2), 157-166, 2000 | 105 | 2000 |
| Pentylenetetrazol-induced seizures and kindling: changes in free fatty acids, superoxide dismutase, and glutathione peroxidase activity V Eraković, G Župan, J Varljen, A Simonić Neurochemistry international 42 (2), 173-178, 2003 | 100 | 2003 |
| Macrolide antibiotics broadly and distinctively inhibit cytokine and chemokine production by COPD sputum cells in vitro N Marjanović, M Bosnar, F Michielin, DR Willé, T Anić-Milić, O Čulić, ... Pharmacological research 63 (5), 389-397, 2011 | 90 | 2011 |
| Anti-inflammatory mechanism of action of azithromycin in LPS-stimulated J774A. 1 cells M Banjanac, VM Kos, K Nujić, M Vrančić, D Belamarić, S Crnković, ... Pharmacological research 66 (4), 357-362, 2012 | 85 | 2012 |
| Altered activities of rat brain metabolic enzymes caused by pentylenetetrazol kindling and pentylenetetrazol—induced seizures V Eraković, G Župan, J Varljen, J Laginja, A Simonić Epilepsy Research 43 (2), 165-173, 2001 | 80 | 2001 |
| Impairment of lysosomal functions by azithromycin and chloroquine contributes to anti-inflammatory phenotype K Nujić, M Banjanac, V Munić, D Polančec, VE Haber Cellular immunology 279 (1), 78-86, 2012 | 75 | 2012 |
| Differences in assessment of macrolide interaction with human MDR1 (ABCB1, P-gp) using rhodamine-123 efflux, ATPase activity and cellular accumulation assays V Munić, Ž Kelnerić, L Mikac, VE Haber European journal of pharmaceutical sciences 41 (1), 86-95, 2010 | 68 | 2010 |
| Azithromycin inhibits macrophage interleukin-1β production through inhibition of activator protein-1 in lipopolysaccharide-induced murine pulmonary neutrophilia M Bosnar, S Čužić, B Bošnjak, K Nujić, G Ergović, N Marjanović, I Pašalić, ... International immunopharmacology 11 (4), 424-434, 2011 | 64 | 2011 |
| Azithromycin drives in vitro GM-CSF/IL-4-induced differentiation of human blood monocytes toward dendritic-like cells with regulatory properties DS Polančec, V Munić Kos, M Banjanac, M Vrančić, S Čužić, D Belamarić, ... Journal of leukocyte biology 91 (2), 229-243, 2012 | 58 | 2012 |
| Electroconvulsive shock in rats: changes in superoxide dismutase and glutathione peroxidase activity V Eraković, G Župan, J Varljen, S Radošević, A Simonić Molecular brain research 76 (2), 266-274, 2000 | 53 | 2000 |
| Intensity of macrolide anti-inflammatory activity in J774A. 1 cells positively correlates with cellular accumulation and phospholipidosis V Munić, M Banjanac, S Koštrun, K Nujić, M Bosnar, N Marjanović, J Ralić, ... Pharmacological research 64 (3), 298-307, 2011 | 49 | 2011 |
| Synthesis and biological activity of 4 ″-O-acyl derivatives of 14-and 15-membered macrolides linked to ω-quinolone-carboxylic unit MM Škugor, V Štimac, I Palej, Đ Lugarić, HČ Paljetak, D Filić, M Modrić, ... Bioorganic & medicinal chemistry 18 (17), 6547-6558, 2010 | 46 | 2010 |
Michael J ParnhamSenior Advisor, EpiEndo Pharmaceuticals; Co-founder, Phialogics AG在 epiendo.com 的电子邮件经过验证
